CD207 and Alzheimer disease: We found that the CD207 expression in the lymphoid nodes of AD mice was downregulated by 6.4 and 12.8 g/kg of HLJDT; moreover, LCs mediate epidermal sensitization by CD207, which stimulates the allergic response that causes AD development (Lee et al., 2012).